QuickView for stomach neuroendocrine cell differentiation (biogroup)

1. L1000 CMAP - Embryonic kidney 293T cells with shRNA-mediated gene knockdown
2. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)

There were no matches for stomach neuroendocrine cell differentiation

1. Capecitabine and Temozolomide for Neuroendocrine Cancers
2. Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
3. TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors
4. Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin
5. Cabozantinib in High Grade Neuroendocrine Neoplasms